Viral load
[대역어] 바이러스 부하
[용어속성] Term
[용어속성] Term
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
Article
[키워드] 95% CI
Ad26.COV2.S
Ad26.COV2.S vaccine
age
Analysis
anti-SARS-CoV-2
Anti-spike
antibody
Antibody Response
Antiretroviral therapy
approved
assays
BNT162b2
CD4+ T-cell
CD8+ T-cell
ChAdOx1-S
comparable
Concentration
conducted
Control
controls
COVID-19
defined
ELISPOT
Endpoint
Environment
Final
generally mild
geometric
HIV
HIV-negative
IFN-γ
immunogenic
immunogenicity
Increased
IQR
less
maintain
male
marker
median age
mRNA vaccination
mRNA vaccine
mRNA-1273
mRNA-based vaccines
Netherland
Netherlands
of BNT162b2
PLWH
predicted
primary endpoint
prospective cohort study
Public
reactogenicity
receiving
recipients
reduced
Registered
remained
required
response
SARS-CoV-2 antibody
SARS-CoV-2 IgG
SARS-CoV-2 spike peptide
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
secondary
Serious Adverse Events
serological response
Sex
suppressed
T-cell Response
the median
the vaccine
Trial
vaccination
Vaccine
vaccine group
Viral load
with HIV
[DOI] 10.1371/journal.pmed.1003979 PMC 바로가기
[DOI] 10.1371/journal.pmed.1003979 PMC 바로가기
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
Article
[키워드] Abbott
Affect
Analysis
analyzed
Antigen
carried
Characteristics
Clinical characteristics
clinical information
collected
COVID-19
Decreased
Delta
delta variant
Diagnosis
diagnostic
diagnostics
Effectiveness
Epidemic
evaluate
explained
Factor
Health care worker
individual
Infection
International
less
load
Lower
marker
median
Mutation
nasopharyngeal specimen
National
omicron
PanBio
performed
positive
question
Rapid
Rapid diagnostic test
RDT
RDTs
reduced
repeated
replicate
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variant
screening strategy
sensitivity
shown
significantly higher
significantly lower
specific mutation
Test
the disease
Variability
variant
variants
variants of concern
Viral load
viral replication
Virological
VoC
[DOI] 10.1128/spectrum.01922-22 PMC 바로가기
[DOI] 10.1128/spectrum.01922-22 PMC 바로가기
A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2
Article
[키워드] 95% confidence interval
access
Accuracy
acute respiratory syndrome
Ag-RDT
Ag-RDTs
Analysis
Antigen-detecting rapid diagnostic tests
B.1.1.7
characterized
circulating
clinical
Combination
complement
coronavirus
COVID-19
Critical
cycle threshold
demonstrated
diagnostic
Emergency
Emergency use
evaluated
facilitate
Factor
Germany
gold standard
highlight
independent
India
multicenter
nasopharyngeal
Oropharyngeal
overcome
participant
Participants
performance
performed
point-of-care
positive
post-symptom onset
questionnaire
raised
Rapid
Rapid diagnostic test
recruited
resources
reverse transcription-PCR
RT-PCR
RT-PCR testing
SARS-CoV-2
SARS-COV-2 infection
sensitivity
specificity
subgroup
subgroups
Support
SUS
Swab
symptom duration
symptom onset
Symptoms
Test
Transmission
variant
Viral load
was used
WHO
widespread
World Health Organization
[DOI] 10.1128/spectrum.01229-22 PMC 바로가기
[DOI] 10.1128/spectrum.01229-22 PMC 바로가기
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy
Article
[키워드] Analysis
antibodies
antibody
antiviral efficacy
association
bamlanivimab/etesevimab
casirivimab/imdevimab
clinical
conducted
Course
COVID-19
Delta
Dual therapy
Efficacy
France
genomic
glycoprotein
growth
high risk
highlight
joint
management
monoclonal
monoclonal antibodies
monoclonal antibody
Mutation
mutation selection.
neutralization
omicron
overlap
Paris
Patient
patients died
patients treated
Prevent
Protein
resistance mechanism
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 variant
SARS-CoV-2-positive patients
selected
selective
severe COVID-19
spike
Spread
the Spike
therapy
treat
Treatment
treatment initiation
variant
variants
viral genome
Viral load
viral mutation
was done
[DOI] 10.1128/spectrum.02152-22 PMC 바로가기
[DOI] 10.1128/spectrum.02152-22 PMC 바로가기
Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
Article
[키워드] Alpha variant
Analysis
Asia
association
B.1.1.7 lineage
B.1.617.2
Breakthrough infection
circulating
Cluster
Complete
conducted
coronavirus disease
COVID-19
Delta
delta variant
demonstrated
determine
diagnostic
dominant
epidemiologically
evaluate
Evidence
Factor
genomic
genotyping
highest
increase in
independent
individual
individuals
Infection
Infectious virus
information
Isolation
Lineage
New York
PCR
peaked
performed
phylogenetic clusters
positive
real-time reverse transcriptase
Replication
SARS-CoV-2
SARS-CoV-2 lineage
secretion
sequence
spread to
subset
Surveillance
the SARS-CoV-2
Transmission
transmission clusters
transmission of SARS-CoV-2
vaccinated individual
vaccinated individuals
vaccination rate
Viral load
viral RNA load
viral titer
virological assessment
virus
Virus titration
VoC
[DOI] 10.1128/spectrum.00563-22 PMC 바로가기
[DOI] 10.1128/spectrum.00563-22 PMC 바로가기
Advanced setup for safe breath sampling and patient monitoring under highly infectious conditions in the clinical environment
Article
[키워드] Analysis
being
Biomarker
breath
caused
Compound
condition
conditions
contagious
disease transmission
Effects
examined
immediate effect
Infection
infection risk
infectious condition
intensive care
Observed
offer
Patient
physiological
point-of-care
profiles
protocol
provided
proximal
reduce
respiratory infections
respiratory rate
risk
Safe
SARS-CoV-2
specific effect
subject
Transmission
Viral load
VoC
VOCs
[DOI] 10.1038/s41598-022-22581-7 PMC 바로가기
[DOI] 10.1038/s41598-022-22581-7 PMC 바로가기
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
Article
[키워드] acting
acute respiratory syndrome
added
Administered
administration
Amplicon sequencing
analyses
Analysis
antibody
Antiviral
antiviral property
antiviral strategy
applied
Bacteria
benefit
Care
chills
collected
Combined
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
detectable
Diagnosis
diarrhea
double-blind
dried blood spot
eligible
evaluated
Fever
Health
hospital
Hospitalization
infected with SARS-CoV-2
Lactobacillaceae
lactobacilli
Microbiome
modulation
multifactorial
nasopharyngeal viral load
nose-throat swab
online questionnaire
Outpatient
Pain
Patient
per-protocol analysis
Placebo
placebo-controlled trial
positive
potential mechanism
practitioners
qPCR
quantitative PCR
Randomized
reduce
reducing
reported
reported symptom
respiratory tract infection
respiratory viral disease
SARS-CoV-2
selected
sequence
severity
significantly
spray
strain
Symptom
symptom resolution
the patient
the placebo group
therapy
Throat
throat spray.
Treatment
Trial
trials
upper respiratory tract
Vaccines
variant
Viral diseases
viral infection
Viral load
was performed
[DOI] 10.1128/spectrum.01682-22 PMC 바로가기
[DOI] 10.1128/spectrum.01682-22 PMC 바로가기
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine
Article
[키워드] ACM
acute respiratory syndrome
adverse effect
airway
antibodies
antibody
antigen presenting cells
artificial
Beta
Beta spike
C57BL/6
cell membrane
clinical symptom
clinical trial
component
conditions
coronavirus
coronavirus disease
COVID-19
CpG
cross-neutralizing
current
delivery of cargo
dendritic cells
dose
doses
evaluate
evaluated
Formulation
generate
Generation
Good
hamster
hamsters
immune responses
immunization
immunogenic
induce
Infection
initiated
interval
intranasal
mice
neutralize
neutralizing antibody
neutralizing responses
New
omicron
Phase 1
polymersome
Practice
PROTECT
reduction
repeated
Safety
SARS-CoV-2
second
serum IgG
spike
Spike protein
Spike-based vaccine
Support
Toxicity
upper respiratory tract
Vaccine
variants
viral clearance
Viral load
virus
weight loss
wild type
[DOI] 10.1021/acsnano.2c06350 PMC 바로가기
[DOI] 10.1021/acsnano.2c06350 PMC 바로가기
Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study
Article
[키워드] Accuracy
Ag-RDT
Ag-RDTs
analyses
Antigen
antigen detection
antigen test
asymptomatic individual
COVID-19
cross-sectional
cross-sectional study
cut-off
diagnostic
Diagnostic accuracy
diagnostic test
Diagnostic test accuracy
E-gene
General population
individual
Interpretation
molecular
molecular test
MOST
nasal
Nasal test
Negative predictive value
participant
Participants
positive
Positive predictive value
presenting
public health
Rapid
rapid antigen detection test
Roche Diagnostics
Saliva
saliva test
SARS-CoV-2
SARS-CoV-2 detection
SARS-COV-2 infection
SARS-CoV-2 testing
SD Biosensor
sensitivity
subgroups
Symptom
symptomatic and asymptomatic
Viral load
[DOI] 10.1186/s12916-022-02603-x PMC 바로가기
[DOI] 10.1186/s12916-022-02603-x PMC 바로가기